HHS Shifts Remdesivir Distribution To Gilead As Supply Crunch Eases

 
• By Joanne S. Eglovitch

AmerisourceBergen will continue to serve as the sole US distributor of Veklury (remdesivir) through the end of this year and will continue to sell the the COVID-19 treatment directly to hospitals.

Remdesivir
Hospital Pharmacies Not Ordering Enough Remdesivir To Justify HHS Distribution • Source: Shutterstock

More from Distribution/Supply Chain

More from Compliance